Clinical Trial Update: Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating systemic therapy alone versus systemic therapy plus radiotherapy for oligometastatic renal cell carcinoma is currently recruiting at Sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Samsung Medical Center | Conditions: Kidney Neoplasm | Phase 3 | Status: RECRUITING